These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8638735)

  • 1. In situ activation of mouse alveolar macrophages by aerosolized liposomal IFN-gamma and muramyl tripeptide.
    Goldbach P; Dumont S; Kessler R; Poindron P; Stamm A
    Am J Physiol; 1996 Mar; 270(3 Pt 1):L429-34. PubMed ID: 8638735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent in situ activation of murine lung macrophages and therapy of melanoma metastases by systemic administration of liposomes containing muramyltripeptide phosphatidylethanolamine and interferon gamma.
    Fidler IJ; Fan D; Ichinose Y
    Invasion Metastasis; 1989; 9(2):75-88. PubMed ID: 2496047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide.
    Fidler IJ; Fogler WE; Brownbill AF; Schumann G
    J Immunol; 1987 Jun; 138(12):4509-14. PubMed ID: 3584979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ.
    Pahl JH; Kwappenberg KM; Varypataki EM; Santos SJ; Kuijjer ML; Mohamed S; Wijnen JT; van Tol MJ; Cleton-Jansen AM; Egeler RM; Jiskoot W; Lankester AC; Schilham MW
    J Exp Clin Cancer Res; 2014 Mar; 33(1):27. PubMed ID: 24612598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria monocytogenes.
    Melissen PM; van Vianen W; Bidjai O; van Marion M; Bakker-Woudenberg IA
    Biotherapy; 1993; 6(2):113-24. PubMed ID: 8398570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse interferon-gamma in liposomes: pharmacokinetics, organ-distribution, and activation of spleen and liver macrophages in vivo.
    Hockertz S; Franke G; Kniep E; Lohmann-Matthes ML
    J Interferon Res; 1989 Oct; 9(5):591-602. PubMed ID: 2507661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells.
    Kurzman ID; Shi F; Vail DM; MacEwen EG
    Cancer Biother Radiopharm; 1999 Apr; 14(2):121-8. PubMed ID: 10850295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical liposomal muramyl tripeptide phosphatidylethanolamine treatment of human bladder carcinoma growing in nude mice.
    Dinney CP; Tanguay S; Bucana CD; Eve BY; Fidler IJ
    J Interferon Cytokine Res; 1995 Jun; 15(6):585-92. PubMed ID: 7553228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I; Fidler IJ
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A.
    Tanguay S; Bucana CD; Wilson MR; Fidler IJ; von Eschenbach AC; Killion JJ
    Cancer Res; 1994 Nov; 54(22):5882-8. PubMed ID: 7954418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muramyl tripeptide phosphatidylethanolamine encapsulated in liposomes stimulates monocyte production of tumor necrosis factor and interleukin-1 in vitro.
    Maeda M; Knowles RD; Kleinerman ES
    Cancer Commun; 1991; 3(10-11):313-21. PubMed ID: 1722107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of nonspecific antimicrobial resistance of mice to Klebsiella pneumoniae septicemia by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine and interferon-gamma alone or combined.
    ten Hagen TL; van Vianen W; Bakker-Woudenberg IA
    J Infect Dis; 1995 Feb; 171(2):385-92. PubMed ID: 7844375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
    Fogler WE; Fidler IJ
    Int J Immunopharmacol; 1987; 9(2):141-50. PubMed ID: 3583507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergic effect of interferon gamma combined with liposomes containing muramyl tripeptide on human monocyte cytotoxicity against fresh allogeneic and autologous tumor cells.
    Galligioni E; Santarosa M; Favaro D; Spada A; Talamini R; Quaia M
    Tumori; 1994 Oct; 80(5):385-91. PubMed ID: 7839471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
    Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
    J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration.
    Kleinerman ES; Jia SF; Griffin J; Seibel NL; Benjamin RS; Jaffe N
    J Clin Oncol; 1992 Aug; 10(8):1310-6. PubMed ID: 1634921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.
    Eue I; Kumar R; Dong Z; Killion JJ; Fidler IJ
    J Immunother; 1998 Sep; 21(5):340-51. PubMed ID: 9789196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
    Phillips NC; Rioux J; Tsao MS
    Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.